• Daily Marijuana Observer Facebook
  • Daily Marijuana Observer Twitter
  • Daily Marijuana Observer StockTwits
  • Daily Marijuana Observer SA
  • Daily Marijuana Observer Instagram
  • Daily Marijuana Observer Youtube
  • Pinterest Social Icon
  • Daily Marijuana Observer Talk Market

Insider Selling by CanniMed Therapeutics' Chief Research Officer

August 2, 2017

 

CanniMed Therapeutics' (TSX:CMED)(OTC:CMMDF)(FRA:0GB) Chief Research Officer, Dr. Larry Holbrook recently filed with SEDI concerning his sales of CanniMed shares. Although the shares he sold make up only a small fraction of CanniMed's 22.7 million shares outstanding, it’s a good idea to keep abreast of what insiders are doing in the markets regardless of the transaction size. 

 

Insider Selling by Chief Research Officer, Dr. Larry Holbrook

 

On July 31st, Dr. Larry Holbrook made seven separate sales of CanniMed Shares:

 

  • 200 shares sold at $10.11 CAD/per share = $2,022 CAD

  • 100 shares sold at $10.05 CAD/per share = $1,005 CAD

  • 7,200 shares sold at $10.025 CAD/per share = $72,180 CAD

  • 300 shares sold at $10.083 CAD/per share = $3,025 CAD

  • 500 shares sold at $10.08 CAD/per share = $5,040 CAD

  • 600 shares sold at $10.07 CAD/per share = $6,042 CAD

  • 100 shares sold at $10.05 CAD/per share = $1,005 CAD

 

In total, Dr. Holbrook sold 9,000 shares for gross proceeds of $90,319 CAD (~$71,885 USD) After these sales, Dr. Holbrook beneficially owns 91,000 shares of CMED. 

 

Conclusion

 

We're working on a marijuana stock profile for CanniMed, so check back soon and be sure to subscribe to our free Canadian licensed producer newsletter to get updates from Canada's 52 ACMPR licensed producers including CanniMed.

 

Don't be a stranger, connect with The Daily Marijuana Observer on FacebookTwitterStockTwits and Instagram!

 

D/M/O

 

Disclaimer
 
Investing in nanocap, microcap, and small cap stocks is highly speculative. The publishers of DailyMarijuanaObserver.com are not registered as Investment Advisors or Broker-Dealers in any jurisdiction whatsoever. The information contained on DailyMarijuanaObserver.com (“this site”) has been prepared solely for informational purposes. Nothing on the site is an offer or solicitation to buy or sell securities. Investors should seek financial advice regarding the appropriateness of investing in any securities mentioned from their financial advisor.

Please reload

LATEST NEWS
Please reload

Please reload

DMO

© Copyright 2016-2020 Smoke Show Ventures, Inc.

RSS Feed

Disclaimer: Except for the historical information and data presented herein, matters discussed in articles on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future performance or achievements expressed or implied by such coverage. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. Before making specific investment decisions, readers should seek their own professional advice and that of their own professional financial adviser. Smoke Show Ventures, Inc. or its affiliates, which owns The Daily Marijuana Observer, may be compensated for its services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.dailymarijuanaobserver.com/legal-disclaimer/.